Avalyn Pharma Inc. · NASDAQ:AVLN

Baranowski Lyn sold 52,500 Avalyn Pharma Inc. shares (Form 4)

Traded Nov 17 to Nov 18, 2026 · Filed Nov 19, 2026

From Nov 17 to Nov 18, 2026, Baranowski Lyn (Director, Chief Executive Officer) sold 52,500 Avalyn Pharma Inc. shares at an average US$27.84 for US$1.46M under a trading plan, leaving 0 shares. Filed Nov 19, 2026 (Form 4).

Sold
52,500 shares
Price
US$27.84 average (US$27.76 to US$29.22)
Value
US$1.46M
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockOption exercise45,300US$4.6245,300Direct
Nov 17, 2026Common StockSale39,600US$27.765,700Direct
Nov 17, 2026Common StockSale5,300US$28.15400Direct
Nov 17, 2026Common StockSale400US$29.220Direct
Nov 18, 2026Common StockOption exercise7,200US$4.627,200Direct
Nov 18, 2026Common StockSale6,465US$27.90735Direct
Nov 18, 2026Common StockSale735US$28.360Direct

Source

Download original · View original at SEC

Related